Polycystic ovary syndrome (PCOS)

  • Kanchan Choudhary G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.
  • Ranjan Singh G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.
  • Ajay Garg G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.
  • Nitesh Verma G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.
  • Anjali Purohit G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan
  • Deepika Deora G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.


Polycystic ovary syndrome (PCOS), also known as Stein-Leventhal Syndrome, was first described in 1935. PCOS, which may also be referred to as polycystic ovary disease is the most common hormonal disorder found in premenopausal women. PCOS is the most common endocrine disorder in women of reproductive age and is the most common cause of infertility due to ovulation. A PCOS is an endocrine disorder which affects the adolescent girls. A PCOS is a condition in which a woman has an imbalance of female sex hormones. This may lead to changes in the menstrual cycle, cyst in the ovary, failure to conceive, and other health problems. It is a common health problem among teenagers and young women. It affects 5–10% of women in their reproductive years. These problems cause infertility. Two principal components to diagnose this syndrome are menstrual dysfunction and clinical or laboratory hyperandrogenism in which these items are used in clinical diagnosis. PCOS is a hormonal disorder that affects between 5% and 10% of women of reproductive age and remains the most enigmatic reproductive disorders. The most common symptoms of PCOS are obesity, acne, amenorrhea, irregular menstrual cycles, hirsutism, insulin resistance (IR), and high cholesterol. Due to the varied nature of PCOS and the large range of possible signs and symptoms, health personnel need a thorough knowledge of the disorder and its management. It is a major disorder characterized by elevated levels of male hormones (androgens), acne, and hirsutism. It can even cause IR, anovulation, and infertility on prolonging incidence of cysts. One of the treatments for PCOS is the use of synthetic medicine, which can help to treat PCOS but with side effects. However, many women who suffer from PCOS opt to use alternative medicine in conjunction with traditional medicine to improve their condition. There are some herbs that are very helpful in treating PCOS. Since PCOS is a curable disorder, it can be cured by the use of natural remedies or allopathic medication. There is a growing interest in herbal remedies or allopathic medication to cure the PCOS. There is a need to change the lifestyle management, diet to control the PCOS level. The natural remedies include treatment with phytoestrogenic and non-estrogenic herbs such as Licorice, Ginseng, Black cohosh, Dong, soy, evening primrose, honey, fenugreek, Schisandra root, and many other which are effective and safe. Many plants have been highly esteemed sources and have advantages which reduce PCOS and also having a hypoglycemic effect. In this review, an attempt has been made to study the use of natural remedy for the treatment of PCOS.

Keywords: Hirsutism,, Polycystic ovary syndrome,, Hyperandrogenism

Author Biography

Kanchan Choudhary, G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan.

assistant professor

Department of pharmacology


1. Available from: syndrome. [Last accessed on 2018 Dec 27].
2. Balaji S, Amadi C, Prasad S, Kasav JB, Upadhyay V, Singh AK. Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India. BioMed Res Int 2015;2015:10.
3. Available from: ;year=2014;volume=18 ;issue=3;page=317;epage=324;aulast=Joshi. [Last accessed on 2018 Dec 28].
4. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. The current description and future need for multidisciplinary PCOS clinics. J Clin Med 2018;7:E395.
5. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004;60:1-7.
6. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:671-83.
7. Available from: [Last accessed on 2018 Jan 02].
8. Azziz R. Introduction. Fertil Steril 2016;106:45.
9. Bani Mohammad M, Majdi Seghinsara A. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev 2017;18:17-21.
10. Sunanda B. Lecturer, Department of OBG Nursing, Nitte Usha Institute of Nursing Sciences, Nitte University, Paneer, Mangalore-575018.
11. Available from: view/1493/1422. [Last accessed on 2019 Jan 07].
12. Available from: publication/311593212_A_CASE_STUDY_ON_POLYCYSTIC_ OVARIAN_SYNDROME_IN_WOMEN_WITH_ACNE. [Last accessed on 2019 Jan 12].
13. Bautista MJ, Kuwahara BS, Henderson CU. Transcutaneous oxygen monitoring in an infant undergoing tracheoesophageal fistula repair. Can Anaesth Soc J 1986;33:505-8.
14. Kouvalainen K, Salmi A, Salmi TT. Infantile herpes zoster. Scand J Infect Dis 1972;4:91-6.
15. Guyatt G, Weaver B, Cronin L, Dooley JA, Azziz R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 2004;57:1279-87.
16. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: Experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453-62.
17. Ferriman D, Purdie AW. The aetiology of oligomenorrhoea and/or hirsuties: A study of 467 patients. Postgrad Med J 1983;59:17-20.
18. Ichino A, Becker S. Estimation of average treatment effects based on propensity scores. Stata J 2002;2:358-77.
19. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
20. Trotter M. A Study of Facial Hair in the White and Negro Races. Vol. 9. St. Louis, MO: Washington University Press; 1922. p. 273-89.
21. Tsai RY, Lee SH, Chan HL. The distribution of follicular units in the Chinese scalp: Implications for reconstruction of natural-appearing hairlines in orientals. Dermatol Surg 2002;28:500-3.
22. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-12.
23. Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med (Berl) 2005;83:97-109.
24. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. Adults. The third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998;21:518-24.
25. Derksen J, Moolenaar AJ, Van Seters AP, Kock DF. Semiquantitative assessment of hirsutism in Dutch women. Br J Dermatol 1993;128:259-63.
26. Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004;191:1914-20.
27. Sagsoz N, Kamaci M, Orbak Z. Body hair scores and total hair diameters in healthy women in the Kirikkale region of turkey. Yonsei Med J 2004;45:483-91.
28. Lunde O, Grøttum P. Body hair growth in women: Normal or hirsute. Am J Phys Anthropol 1984;64:307-13.
29. Muti P, Trevisan M, Panico S, Micheli A, Celentano E, Freudenheim JL, et al. Body fat distribution, peripheral indicators of androgenic activity, and blood pressure in women. Ann Epidemiol 1996;6:181-7.
30. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman gallwey self-scoring I: Performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4112-4.
131 Views | 11 Downloads
How to Cite
Kanchan Choudhary, Ranjan Singh, Ajay Garg, Nitesh Verma, Anjali Purohit, & Deepika Deora. (2019). AN UPDATED OVERVIEW OF POLYCYSTIC OVARY SYNDROME. Innovare Journal of Medical Sciences, 7(3), 1-13. Retrieved from
Review Article(s)